The HealthTech Award ceremony took place on 19 October last, in the luxurious setting of the Théâtre de la Tour Eiffel. Of the one hundred or more contenders, seven companies stood out to the 17-member jury.
Two members of the French government took part in the ceremony by video link. Olivier Véran, Minister of Solidarity and Health, recalled that France aims to become the European leader in health innovation, an ambition supported by an investment of over €7 billion under the “France 2030” plan.
Cédric O, Secretary of State for Digital Transition and Electronic Communication added that “biotech companies are the future of healthcare”.
“The award-winners have made great strides in their development despite the unprecedented conditions. They have shown audacity and resilience in their shared commitment to transform patients’ lives through new medical solutions”, Franck Mouthon, President of France Biotech.
The winner of the Young HealthTech Company award was Arkhn. Arkhn has developed a data architecture solution for healthcare institutions that organises data from hospital information system software in the standard FHIR format.
The E-health trophy was awarded to Aqemia. Aqemia has developed a portfolio of drug discovery programmes using a unique therapeutic molecule design platform.
The Medical Diagnostics trophy was awarded to OncoDiag for its new, non-invasive cancer screening, diagnosis and monitoring tests.
The Biotech trophy went to Alderaan Biotechnology, which develops therapeutic antibodies for cancer treatment.
CorWave, the MedTech trophy winner, develops heart-assist pumps using a breakthrough biomimetic technology.
Sophie Brac de la Perrière, CEO of Healshape, has developed a personalised, natural, regenerative and resorbable bioprosthesis for women who have had a mastectomy following breast cancer. She was awarded the Women’s HealthTech Entrepreneurship trophy.
Lastly, the Coup de Coeur trophy was awarded to Robeauté for its submillimetric microrobot that can reach hard to access areas, including in the brain, thus enabling tailored treatments or delicate medical procedures such as microbiopsies or measurements.